Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Do June’s CPI Numbers Mean More Interest Rate Hikes? Experts Are Watching Other Indicators For a Better Answer

The dance between inflation and interest rates is a delicate one, and the Federal Reserve’s role as the choreographer is critical. With the release of June’s CPI report, how should businesses gauge the health of the market and the chance for further interest rate hikes. What will be the Federal Reserve’s next move? June’s…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

The dance between inflation and interest rates is a delicate one, and the Federal Reserve’s role as the choreographer is critical. With the release of June’s CPI report, how should businesses gauge the health of the market and the chance for further interest rate hikes. What will be the Federal Reserve’s next move?

June’s CPI report, which looks back on May’s consumer prices, saw a modest rise of 0.1% in consumer prices month-over-month, falling below the predicted 0.2% and marking a deceleration from April’s 0.4% increase. The 12-month inflation rate also dropped to 4.0%, a significant decrease from April’s 4.9%. Notably, the core index, excluding food and energy, held steady at 0.4% for the month, while the annual inflation rate softened to 5.3% from 5.5%.

The Federal Reserve is expected to welcome this decline in inflation, the lowest CPI numbers since March 2021 for the headline rate and November 2021 for the core index. However, the Federal Open Market Committee (FOMC) is not entirely satisfied yet, as other important gauges of economic health will probably motivate their next steps. For this reason, experts are waiting with bated breath for further reports that will better reveal how the Fed will move forward with its monetary policy.

Dr. Russell Rhoads, Director of Research at United Ethos Wealth Partners, breaks down why he’s waiting to make a final assessment on the ripple effects of June’s CPI until he sees more numbers, and which numbers are most critical for businesses to watch closely.

Russell’s Thoughts

“CPI came in at 4% this week, lowest reading we’ve had in a really, really long time, and we are definitely trending in the right direction, but we’re not quite where the Fed would like to see that number.

Now, the FOMC periodically revisits their employment targets, their growth targets, and their inflation targets. And they’re due to do this in the next few months, and there are rumblings out there that they may raise the CPI, the tolerable CPI, up to something around 3% at the most. So we’re still not where the FOMC would like us. Now, they did pause hiking rates at the last meeting, but the dot plot is targeting 5.6% by the end of the year as the risk-free rate, which would be two hikes.

Now, currently, the futures market, which I like to pay more attention to, is only pricing in one more hike. They’re pricing this in at the late July meeting. This means if you are concerned with respect to what the Fed’s going to do, pay very close attention to the PCE, PPI, and CPI. They’re going to be paying very close attention to the inflation numbers that come out in July.

Right now, we’ve got that hike priced in, and then according to the markets, not the dot plot, there’s a disconnect between the markets and the dot plot. The dot plot has us doing two hikes, the futures markets have us at one hike and then pause through the rest of the year. The only real change is the futures markets a couple of weeks ago had us at a hike in July and then a cut before the year is over with. That cut seems to be off the table.”

Article written by Daniel Litwin.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512